Patents by Inventor Thomas Ehrhardt

Thomas Ehrhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070113300
    Abstract: The present invention relates to Clp-protease, which, when absent, brings about reduced growth and chlorotic leaves as target for herbicides. For this purpose, novel nucleic acid sequences encompassing SEQ ID NO:3, SEQ ID NO:11 and SEQ ID NO: 17 and functional equivalents of SEQ ID NO:3, SEQ ID NO:11 and SEQ ID NO: 17 are provided. Moreover, the present invention relates to the use of Clp-protease in a method for identifying compounds with herbicidal or growth-regulatory activity, and to the use of the compounds identified by this method as herbicides or growth regulators.
    Type: Application
    Filed: November 30, 2004
    Publication date: May 17, 2007
    Applicant: BASF Aktiengesellschaft
    Inventors: Thomas Ehrhardt, Andreas Reindl, Annette Freund, Ralf-Michael Schmidt, Uwe Sonnewald, Marc Nigel, Wolfgang Lein, Frederik Bornke, Kirsten Deist
  • Publication number: 20070042451
    Abstract: The invention relates to the use of glycine decarboxylase complex, which is used as a target for herbicides in the absence of growth retardations and chlorotic leaves. Novel nucleic acid sequences comprising SEQ ID NO:1 and functional equivalents of SEQ ID NO:1 are thus disclosed. The invention also relates to the use of glycine decarboxylase complex and the functional equivalents thereof in a method for identifying compounds having a herbicidal or growth-regulatory effect, in addition to the use of said compounds identified via said method as herbicides or growth regulators.
    Type: Application
    Filed: October 27, 2004
    Publication date: February 22, 2007
    Applicant: BASF Aktiengesellschaft
    Inventors: Thomas Ehrhardt, Andreas Reindl, Annette Freund, Ralf-Michael Schmidt, Uwe Sonnewald, Marc Nigel, Wolfgang Lein, Frederik Bornke, Kirsten Deist
  • Publication number: 20070003934
    Abstract: The present invention relates to the use of 2-methyl-6-solanylbenzoquinone methyltransferase which, when absent, brings about retarded growth and chlorotic leaves, as target for herbicides. In this context, there are provided novel nucleic acid sequences comprising SEQ ID NO:5 and SEQ ID NO:7 and corresponding functional equivalents. Moreover, the present invention relates to the use of 2-methyl-6-solanylbenzoquinone methyltransferase and its functional equivalents in a method for identifying herbicidal or growth-regulatory compounds, and to the use of the compounds identifed via the method as herbicides or growth regulators.
    Type: Application
    Filed: November 30, 2004
    Publication date: January 4, 2007
    Applicant: BASF AKIENGESELLSCHAFT
    Inventors: Thomas Ehrhardt, Andreas Reindl, Annette Freund, Ralf-Michael Schmidt, Uwe Sonnewald, Marc Nigel, Wolfgang Lein, Frederik Bornke
  • Publication number: 20060058190
    Abstract: The present invention relates to malate dehydrogenase, which, when absent, brings about reduced growth and chlorotic leaves and is encoded by the nucleic acid sequence SEQ ID NO:2 or by a functional equivalent of this nucleic acid sequence, as target for herbicides. For this purpose, novel nucleic acid sequences encompassing SEQ ID NO:2 and functional equivalents of SEQ ID NO:2 are provided. Moreover, the present invention relates to the use of the abovementioned malate dehydrogenase and its functional equivalents in a method for identifying compounds with herbicidal or growth-regulatory activity, and to the use of the compounds identified by this method as herbicides or growth regulators.
    Type: Application
    Filed: December 17, 2003
    Publication date: March 16, 2006
    Inventors: Thomas Ehrhardt, Andreas Reindl, Annette Freund, Ralf-Michael Schmidt, Kirsten Deist, Uwe Sonnewald, Marc Nigel, Wolfgang Lein, Frederik Bornke
  • Publication number: 20060035786
    Abstract: The present invention relates to the use of a polypeptide with the biological activity of a sucrose-6-phosphate phosphatase which, if not present, brings about growth retardation symptoms and chlorotic leaves and which is encoded by the nucleic acid sequences SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5 or by a functional equivalent of SEQ ID NO:1, SEQ ID NO:3 or SEQ ID NO:5 as target for herbicides. Moreover, the present invention relates to the use of the abovementioned polypeptides in a method for identifying herbicidal or growth-regulatory compounds which inhibit sucrose-6-phosphate phosphatase. Moreover, the invention relates to the use of these compounds which have been identified via the method as herbicides or growth regulators.
    Type: Application
    Filed: July 16, 2003
    Publication date: February 16, 2006
    Applicant: BASF Aktiengesellschaft
    Inventors: Thomas Ehrhardt, Uwe Sonnewald, Frederik Bornke, Shuai Chen
  • Publication number: 20050142553
    Abstract: The present invention relates to serine hydroxymethyltransferase (E.C. 2.1.2.1) as novel target for herbicides, and to nucleic acid sequences encoding a polypeptide with the biological activity of a serine hydroxymethyltransferase, which, when not present, bring about growth retardation symptoms and chlorotic leaves, comprising the nucleic acid sequence SEQ ID No:3, and functional equivalents of the abovementioned nucleic acid sequence or the nucleic acid sequence SEQ ID NO:7 and functional equivalents of the abovementioned nucleic acid sequence. Moreover, the present invention relates to the use of the abovementioned nucleic acid sequences, of functional analogs of the SEQ ID NO:3 or SEQ ID NO:7 or of polypeptides encoded by one of the abovementioned nucleic acid sequences in a method for identifying herbicidally active compounds which inhibit serine hydroxymethyltransferases, and to the use of these compounds which have been identified by the method as herbicides.
    Type: Application
    Filed: March 13, 2003
    Publication date: June 30, 2005
    Inventors: Uwe Sonnewald, Frederik Bornke, Kirsten Deist, Marc Nigel, Wolfgang Lein, Thomas Ehrhardt, Andreas Reindl, Ralf-Michael Schmidt, Annette Freund
  • Publication number: 20030157592
    Abstract: Isolated nucleic acid molecules, designated TCMRP nucleic acid molecules, which encode novel TCMRPs from e.g. Phycomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TCMRP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated TCMRPs, mutated TCMRPs, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells, organisms or plants based on genetic engineering of TCMRP genes in these organisms.
    Type: Application
    Filed: June 13, 2002
    Publication date: August 21, 2003
    Inventors: Jens Lerchl, Andreas Renz, Thomas Ehrhardt, Andreas Reindl, Petra Cirpus, Friedrich Bischoff, Markus Frank, Annette Freund, Elke Duwenig, Ralf-Michael Schmidt, Ralf Reski, Ralf Badur
  • Publication number: 20030148311
    Abstract: The present invention relates to the use of DNA sequences of plant origin encoding a polypeptide with aspartate carbamyltransferase (E.C. 2.1.3.2) activity for generating an assay system for finding aspartate carbamyltransferase inhibitors. For the first time, it was shown, with the aid of antisense technology, that aspartate carbamyltransferase constitutes a herbicidal target.
    Type: Application
    Filed: August 27, 2002
    Publication date: August 7, 2003
    Inventors: Thomas Ehrhardt, Jens Lerchl, Marc Stitt Nigel, Rita Zrenner, Tina Maria Ritter
  • Publication number: 20030024003
    Abstract: Isolated nucleic acid molecules, designated GDRP nucleic acid molecules, which encode novel GDRPs from Physcomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing GDRP nucleic acid molecules, and host cells and organisms into which the expression vectors have been introduced. The invention still further provides isolated GDRPs, mutated GDRPs, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells based on genetic engineering of GDRP genes in this organism.
    Type: Application
    Filed: January 25, 2001
    Publication date: January 30, 2003
    Inventors: Markus Frank, Andreas Reindl, Ralf-Michael Schmidt, Annette Freund, Thomas Ehrhardt, Friedrich Bischoff, Andreas Renz, Elke Duwenig, Petra Cirpus, Jens Lerchl, Ralf Reski
  • Publication number: 20020142422
    Abstract: Isolated nucleic acid molecules, designated MP protein nucleic acid molecules, which encode novel MP proteins from e.g. Phycomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MP protein nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MP proteins, mutated MP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells, organisms or plants based on genetic engineering of MP protein genes in these organisms.
    Type: Application
    Filed: December 12, 2000
    Publication date: October 3, 2002
    Inventors: Jens Lerchl, Andreas Renz, Thomas Ehrhardt, Andreas Reindl, Petra Cirpus, Friedrich Bischoff, Markus Frank, Annette Freund, Elke Duwenig, Ralf-Michael Schmidt, Ralf Reski
  • Publication number: 20020064816
    Abstract: Isolated nucleic acid molecules, designated CMRP nucleic acid molecules, which encode novel CMRPs from Physcomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CMRP nucleic acid molecules, and host cells and organisms into which the expression vectors have been introduced. The invention still further provides isolated CMRPs, mutated CMRPs, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells based on genetic engineering of CMRP genes in this organism.
    Type: Application
    Filed: December 13, 2000
    Publication date: May 30, 2002
    Inventors: Jens Lerchl, Andreas Renz, Thomas Ehrhardt, Andreas Reindl, Petra Cirpus, Friedrich Bischoff, Markus Frank, Annette Freund, Elke Duwenig, Ralf-Michael Schmidt, Ralf Reski